| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/06/2006 | CA2582940A1 Myostatin isoform |
| 04/06/2006 | CA2582777A1 Proton pump inhibitors |
| 04/06/2006 | CA2582297A1 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 04/06/2006 | CA2582225A1 Substituted dipiperdine ccr2 antagonists |
| 04/06/2006 | CA2582223A1 Crystalline forms of a pyrazolo '3, 4-c pyridine factor xa inhibitor |
| 04/06/2006 | CA2582222A1 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 04/06/2006 | CA2582071A1 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| 04/06/2006 | CA2582046A1 Halocombstatins and methods of synthesis thereof |
| 04/06/2006 | CA2582041A1 Recombinant human t2 rnase and uses thereof |
| 04/06/2006 | CA2581980A1 Methods for treating conditions associated with the accumulation of excess extracellular matrix |
| 04/06/2006 | CA2581939A1 Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof |
| 04/06/2006 | CA2581932A1 A method of female contraception and a kit for use therein |
| 04/06/2006 | CA2581927A1 Treatment or prevention of unscheduled bleeding in women on progestogen containing medication |
| 04/06/2006 | CA2581926A1 Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride |
| 04/06/2006 | CA2581922A1 1-(.beta.-d-glycopyranosyl)-3-substituted nitrogenous heterocyclic compound, medicinal composition containing the same, and medicinal use thereof |
| 04/06/2006 | CA2581883A1 Novel antimicrobial agents |
| 04/06/2006 | CA2581834A1 Novel crystal form of (3-cyano-1h-indol-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl]methanone, hydrochloride |
| 04/06/2006 | CA2581828A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | CA2581823A1 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | CA2581816A1 Microcapsules comprising a methylxanthine and a corticosteroid |
| 04/06/2006 | CA2581775A1 Dihydropyrimidine microcapsule - formulations |
| 04/06/2006 | CA2581764A1 Minicapsule formulations |
| 04/06/2006 | CA2581741A1 Histamine-3 receptor antagonists |
| 04/06/2006 | CA2581737A1 Proline derivatives |
| 04/06/2006 | CA2581732A1 Carbonyl compounds usable as coagulation factor xa inhibitors |
| 04/06/2006 | CA2581665A1 Osteogenic oligonucleotides and uses thereof |
| 04/06/2006 | CA2581658A1 Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals |
| 04/06/2006 | CA2581652A1 Formulations and methods for treatment of inflammatory diseases |
| 04/06/2006 | CA2581606A1 Carrier-free composition for the treatment of onychomycosis |
| 04/06/2006 | CA2581580A1 Novel substituted thiophencarboxylic acid amides, production thereof and use thereof as medicaments |
| 04/06/2006 | CA2581579A1 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists |
| 04/06/2006 | CA2581523A1 Methods and compositions for treating flaviviruses, pestiviruses and hepacivirus |
| 04/06/2006 | CA2581426A1 Sulfonamide compounds |
| 04/06/2006 | CA2581353A1 Salts of decitabine |
| 04/06/2006 | CA2581322A1 Process for preparing ziprasidone |
| 04/06/2006 | CA2581254A1 Method for synthesizing derivative, compound library and method for constructing the same, and method for screening |
| 04/06/2006 | CA2581224A1 Targeting opposite strand replication intermediates of single-stranded viruses by rnai |
| 04/06/2006 | CA2581209A1 Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks |
| 04/06/2006 | CA2581179A1 6-(pyridinyl)-4 pyrimidone derivatives as tau protein kinase 1 inhibitors |
| 04/06/2006 | CA2581126A1 Carboxy-amido-triazoles for the localized treatment of ocular diseases |
| 04/06/2006 | CA2580962A1 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof |
| 04/06/2006 | CA2580838A1 Substituted heterocyclic compounds and methods of use |
| 04/06/2006 | CA2580824A1 Cyclodextrin inclusion complexes and methods of preparing same |
| 04/06/2006 | CA2580811A1 Carbostyril compound |
| 04/06/2006 | CA2580707A1 Rnai modulation of apob and uses thereof |
| 04/06/2006 | CA2580461A1 Substituted sulfonamidopropionamides and methods of use |
| 04/06/2006 | CA2580139A1 Process for production of 2-chloro-4-nitroimidazole |
| 04/06/2006 | CA2580136A1 Synthesis of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| 04/06/2006 | CA2580129A1 Salts of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation |
| 04/06/2006 | CA2579971A1 A bacterial atp synthase binding domain |
| 04/06/2006 | CA2579240A1 Small molecule modulators of cytokine activity |
| 04/06/2006 | CA2579067A1 Cancer combination therapy comprising azd2171 and imatinib |
| 04/06/2006 | CA2578956A1 Combination comprising zd6474 and an imatinib |
| 04/06/2006 | CA2577467A1 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 04/06/2006 | CA2577185A1 Cyclic diarly ureas suitable as tyrosine kinase inhibitors |
| 04/06/2006 | CA2576172A1 Inhibitors of akt activity |
| 04/06/2006 | CA2575472A1 Hiv inhibiting 5-substituted pyrimidines |
| 04/06/2006 | CA2573999A1 Thienopyrimidines useful as aurora kinase inhibitors |
| 04/06/2006 | CA2573976A1 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 04/05/2006 | EP1642983A1 Arachidonic acid and methods for the production and use thereof |
| 04/05/2006 | EP1642968A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642967A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642907A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642906A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642901A1 Novel erythromycin derivatives |
| 04/05/2006 | EP1642900A1 Tricyclic triazolobenzazepine derivative produced as novel crystalline substance |
| 04/05/2006 | EP1642898A1 Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 04/05/2006 | EP1642897A1 Alpha-crystalline form of Strontium Ranelate, process of preparation therof and pharmaceutical compositions containing it |
| 04/05/2006 | EP1642888A1 compounds for modulating the rage receptor |
| 04/05/2006 | EP1642885A1 Use of a pharmaceutical composition containing a para-aminophenyl acetic acid derivative for treating inflammatory conditions of the gastrointestinal tract |
| 04/05/2006 | EP1642880A1 Hsp90 family protein inhibitors |
| 04/05/2006 | EP1642594A1 Remedy for urinary tract diseases |
| 04/05/2006 | EP1642593A1 Solid pharmaceutical preparation |
| 04/05/2006 | EP1642592A1 Remedy for sarcoidosis and method of treating the same |
| 04/05/2006 | EP1642591A1 MEDICINAL COMPOSITION CONTAINING NF-kAPPA B DECOY FOR TREATING AND PREVENTING RESPIRATORY DISEASES AND METHOD OF USING THE SAME |
| 04/05/2006 | EP1642589A1 Preventives/remedies for snore or respiratory disturbances during sleep |
| 04/05/2006 | EP1642585A1 Osteogenic oligonucleotides and uses thereof |
| 04/05/2006 | EP1642584A1 External preparation for improving coital function |
| 04/05/2006 | EP1642583A2 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 04/05/2006 | EP1642582A1 Low dose entecavir formulation and use |
| 04/05/2006 | EP1642581A2 Treatment of retinal diseases with quinoxaline derivatives |
| 04/05/2006 | EP1642580A1 Sulfonamide substituted imidazoquinolines |
| 04/05/2006 | EP1642579A1 Phentanyl-containing adhesive patch for application to oral-cavity mucosa |
| 04/05/2006 | EP1642578A2 Fentanyl composition for nasal administration |
| 04/05/2006 | EP1642577A1 Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of central neuropathic pain |
| 04/05/2006 | EP1642576A2 Methods, kits and compositions for using pyrrole derivatives to combat anxiety |
| 04/05/2006 | EP1642575A1 Use of r-nsaid's for the prevention of alzheimer's disease |
| 04/05/2006 | EP1642574A2 Combination of a beta-2 adrenoceptor agonist and an aminosugar and their use for the treatment of immunomodulatory disorders |
| 04/05/2006 | EP1642573A1 Use of GABA B receptor modulators for treating gastro-intestinal disorders |
| 04/05/2006 | EP1642571A2 Method for preparing submicron particle suspensions |
| 04/05/2006 | EP1642559A2 Use of creatine and/or creatine derivatives in cosmetic or dermatological preparations |
| 04/05/2006 | EP1642500A2 Antifungal compositions comprising an antifungal compound of the polyene type |
| 04/05/2006 | EP1641811A1 Microbial method for hydrolysis and oxidation of androst-5-ene and pregn-5-ene steroid esters |
| 04/05/2006 | EP1641805A1 Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases |
| 04/05/2006 | EP1641803A1 Thienopyrimidine derivatives as potassium channel inhibitors |
| 04/05/2006 | EP1641799A1 Imidazo-pyridazinone derivatives and imidazo-pyridone derivatives, production thereof, and use thereof as medicaments |
| 04/05/2006 | EP1641797A1 4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7h-pyrrolo `2, 3d]pyrimidine hydrogen mesylate and its polymorphic forms |
| 04/05/2006 | EP1641794A1 Novel pyrrolodihydroisoquinolines useful in the treatment of cancer |
| 04/05/2006 | EP1641793A1 Novel imidazopyridine compound ii with therapeutic effect |
| 04/05/2006 | EP1641792A1 Pyrrolodihydroisoquinolines as pde10 inhibitors |